RMD
ResMed Inc
225.00$
-1.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 66.1% | 43.6% | 47.4% | 34.8% | 27.9% | 33.2% | 33.3% | 37.9% | 35.1% | 34.3% | 42.9% | 48.2% | |
| 32.8% | 22.4% | 23.7% | 6.2% | 3.6% | 10.1% | 6.2% | 5.4% | 3.4% | 3.5% | 14.8% | 16.4% | |
| 32.8% | 22.4% | 23.7% | 6.2% | 3.6% | 10.1% | 6.2% | 5.4% | 3.4% | 3.5% | 14.8% | 16.4% | |
| 16.6% | 11.7% | 13.0% | 15.8% | 12.9% | 10.3% | 13.2% | 11.3% | 10.4% | 12.2% | 12.1% | 11.6% | |
| 11.3% | 6.9% | 7.7% | 8.8% | 8.5% | 9.1% | 9.7% | 14.6% | 14.8% | 12.0% | 11.3% | 10.5% | |
| 17.8% | 11.8% | 11.4% | 12.6% | 9.4% | 11.7% | 12.5% | 12.4% | 9.9% | 10.2% | 8.8% | – | |
| 12.1% | 32.5% | 30.7% | 34.9% | 45.2% | 41.2% | 40.8% | 38.0% | 41.0% | 41.4% | 37.3% | 37.5% | |
| 2.2% | 9.2% | 7.5% | 7.0% | 12.7% | 9.8% | 8.3% | 6.8% | 8.2% | 7.1% | 5.7% | 5.0% | |
| 27.3% | 48.0% | 43.5% | 32.8% | 49.6% | 45.6% | 39.0% | 34.0% | 38.8% | 29.2% | 27.0% | 26.6% | |
| 12.2% | 19.6% | 10.4% | 16.7% | 13.5% | 13.1% | 19.3% | 13.5% | 11.2% | 13.3% | 12.5% | 15.6% | |
| 6.8% | 9.2% | 6.2% | 0.4% | 0.3% | 0.7% | 0.8% | 0.6% | 0.5% | 0.5% | 0.5% | 3.2% | |
| 3.7% | 2.8% | 2.7% | 3.0% | 2.8% | 3.0% | 2.9% | 3.1% | 2.2% | 3.5% | 3.4% | 3.4% | |
| 13.8% | 26.8% | 31.1% | 8.8% | 30.6% | 25.4% | 13.6% | 15.0% | 21.2% | 10.1% | 8.1% | 4.5% | |
| 72.7% | 52.0% | 56.5% | 67.2% | 50.4% | 54.4% | 61.0% | 66.0% | 61.2% | 70.8% | 73.0% | 73.4% | |
| 90.5% | 66.3% | 66.8% | 79.4% | 59.3% | 61.8% | 65.1% | 70.9% | 63.0% | 72.6% | 74.4% | 80.9% | |
| 6.5% | 4.3% | 4.1% | 4.7% | 3.5% | 3.2% | 3.1% | 2.9% | 2.2% | 2.1% | 1.8% | 1.6% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.